BioSpace News Archive

Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, today announced $15 million in financing to advance its technology enabling early detection of sepsis in the emergency department.

Refuge Biotechnologies, Inc. (“Refuge”), a synthetic biology company developing intelligent cell therapeutics for cancer immunotherapy, today announced that Francesco M. Marincola, M.D., chief scientific officer of Refuge, will present during the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting & Pre-Conference Programs (SITC 2019).

Calyxt, Inc., a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019.

National Comprehensive Cancer Network expands resources to meet growing utilization of cell-based cancer treatments

AACC is pleased to announce that its peer-reviewed publication The Journal of Applied Laboratory Medicine has been accepted for indexing in PubMed, one of the largest and most respected databases of medical research in the world.

Galmed Pharmaceuticals Ltd. announced that it will host a conference call and webcast on Wednesday, November 6, 2019, to provide an update on current developments with respect to its clinical programs for Aramchol™ and to discuss financial results for the three and nine months ended September 30, 2019.

Atacama Bio Natural Products s.a. and Lus Health Ingredients b.v. announce a distributorship on the NatAxtin™ range of products for the European market..

WESTLAKE VILLAGE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2019 third quarter and year-to-date financial results and its management will host a conference call to discuss the financial results and corporate updates at 9:00 AM (Eastern Time) on Wednesday, November 6, 2019. Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder. To participate in the live call by telep

Double-digit profit growth through strong profitable business sales

As a BioLabs founding sponsor Eurofins Discovery provides services and support for start-ups in San Diego to accelerate their early-stage drug discovery programs